,date,title,url
0,2017-05-12,奥翔药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-05-12/603229_20170512_1.pdf
1,2017-05-12,奥翔药业：关于《浙江奥翔药业股份有限公司关于股票交易异常波动有关事项的问询函》的回函,/disclosure/listedinfo/announcement/c/2017-05-12/603229_20170512_2.pdf
2,2017-05-17,奥翔药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-05-17/603229_20170517_1.pdf
3,2017-05-17,奥翔药业：关于《浙江奥翔药业股份有限公司关于股票交易异常波动有关事项的问询函》的回函,/disclosure/listedinfo/announcement/c/2017-05-17/603229_20170517_2.pdf
4,2017-05-19,奥翔药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-05-19/603229_20170519_1.pdf
5,2017-05-19,奥翔药业：关于《浙江奥翔药业股份有限公司关于股票交易异常波动有关事项的问询函》的回函,/disclosure/listedinfo/announcement/c/2017-05-19/603229_20170519_2.pdf
6,2017-05-25,奥翔药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-05-25/603229_20170525_1.pdf
7,2017-06-02,奥翔药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-06-02/603229_20170602_1.pdf
8,2017-06-02,奥翔药业：关于《浙江奥翔药业股份有限公司关于股票交易异常波动有关事项的问询函》的回函,/disclosure/listedinfo/announcement/c/2017-06-02/603229_20170602_2.pdf
9,2017-06-03,奥翔药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_20.pdf
10,2017-06-03,奥翔药业关于召开2016年度利润分配事项投资者说明会的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_21.pdf
11,2017-06-03,奥翔药业关于以募集资金置换预先投入募投项目自筹资金的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_12.pdf
12,2017-06-03,奥翔药业关于续聘2017年度审计机构的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_9.pdf
13,2017-06-03,奥翔药业关于修订《公司章程》并办理变更工商登记的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_17.pdf
14,2017-06-03,奥翔药业关于公司向银行申请2017年度综合授信额度的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_11.pdf
15,2017-06-03,奥翔药业关于公司使用闲置募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_15.pdf
16,2017-06-03,奥翔药业关于公司2017年度董事、监事和高级管理人员薪酬计划的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_10.pdf
17,2017-06-03,奥翔药业关于2016年度现金分红情况说明的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_19.pdf
18,2017-06-03,奥翔药业公司章程,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_18.pdf
19,2017-06-03,奥翔药业独立董事关于第一届董事会第二十一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_4.pdf
20,2017-06-03,奥翔药业第一届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_7.pdf
21,2017-06-03,奥翔药业第一届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_1.pdf
22,2017-06-03,奥翔药业：天健会计师事务所关于奥翔药业以自筹资金预先投入募投项目鉴证报告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_5.pdf
23,2017-06-03,奥翔药业：天健会计师事务所关于奥翔药业以自筹资金预先投入募投项目鉴证报告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_14.pdf
24,2017-06-03,奥翔药业：国金证券股份有限公司关于浙江奥翔药业股份有限公司使用闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_16.pdf
25,2017-06-03,奥翔药业：国金证券股份有限公司关于浙江奥翔药业股份有限公司使用闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_2.pdf
26,2017-06-03,奥翔药业：国金证券股份有限公司关于浙江奥翔药业股份有限公司使用募集资金置换募投项目预先投入自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_13.pdf
27,2017-06-03,奥翔药业：国金证券股份有限公司关于浙江奥翔药业股份有限公司使用募集资金置换募投项目预先投入自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_6.pdf
28,2017-06-03,奥翔药业2O16年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_3.pdf
29,2017-06-03,奥翔药业2016年度监事会工作报告,/disclosure/listedinfo/announcement/c/2017-06-03/603229_20170603_8.pdf
30,2017-06-06,奥翔药业关于2016年年度股东大会通知的更正公告,/disclosure/listedinfo/announcement/c/2017-06-06/603229_20170606_1.pdf
31,2017-06-16,奥翔药业2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-16/603229_20170616_1.pdf
32,2017-06-27,奥翔药业2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-27/603229_20170627_2.pdf
33,2017-06-27,奥翔药业2016年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-27/603229_20170627_1.pdf
34,2017-07-07,奥翔药业关于公司使用闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-07-07/603229_20170707_1.pdf
35,2017-07-22,奥翔药业关于完成工商变更登记并换发营业执照的公告,/disclosure/listedinfo/announcement/c/2017-07-22/603229_20170722_1.pdf
36,2017-08-30,奥翔药业关于聘任证券事务代表的公告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_10.pdf
37,2017-08-30,奥翔药业关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_9.pdf
38,2017-08-30,奥翔药业关于公司使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_6.pdf
39,2017-08-30,奥翔药业独立董事关于一届二十二次董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_7.pdf
40,2017-08-30,奥翔药业第一届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_4.pdf
41,2017-08-30,奥翔药业第一届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_3.pdf
42,2017-08-30,奥翔药业：国金证券关于浙江奥翔药业股份有限公司使用闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_8.pdf
43,2017-08-30,奥翔药业2017年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_20170830_5.pdf
44,2017-08-30,奥翔药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-30/603229_2017_zzy.pdf
45,2017-08-30,奥翔药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-30/603229_2017_z.pdf
46,2017-09-13,奥翔药业关于开展远期结售汇业务的公告,/disclosure/listedinfo/announcement/c/2017-09-13/603229_20170913_1.pdf
47,2017-10-31,奥翔药业内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2017-10-31/603229_20171031_4.pdf
48,2017-10-31,奥翔药业第一届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-31/603229_20171031_3.pdf
49,2017-10-31,奥翔药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-31/603229_2017_3.pdf
50,2017-11-29,奥翔药业关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_9.pdf
51,2017-11-29,奥翔药业关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_8.pdf
52,2017-11-29,奥翔药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_3.pdf
53,2017-11-29,奥翔药业独立董事候选人声明（朱大旗）,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_6.pdf
54,2017-11-29,奥翔药业独立董事候选人声明（张福利）,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_5.pdf
55,2017-11-29,奥翔药业独立董事候选人声明（厉国威）,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_4.pdf
56,2017-11-29,奥翔药业独立董事关于第一届董事会第二十五次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_2.pdf
57,2017-11-29,奥翔药业第一届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_7.pdf
58,2017-11-29,奥翔药业第一届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-29/603229_20171129_1.pdf
59,2017-12-06,奥翔药业2017年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-06/603229_20171206_1.pdf
60,2017-12-15,奥翔药业独立董事关于第二届董事会第一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-12-15/603229_20171215_4.pdf
61,2017-12-15,奥翔药业第二届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-15/603229_20171215_5.pdf
62,2017-12-15,奥翔药业第二届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-15/603229_20171215_3.pdf
63,2017-12-15,奥翔药业2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-15/603229_20171215_1.pdf
64,2017-12-15,奥翔药业2017年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-12-15/603229_20171215_2.pdf
65,2018-01-04,奥翔药业关于使用闲置募集资金进行现金管理到期收回并继续购买理财产品的公告,/disclosure/listedinfo/announcement/c/2018-01-04/603229_20180104_1.pdf
66,2018-01-18,奥翔药业：国金证券股份有限公司关于浙江奥翔药业股份有限公司2017年持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2018-01-18/603229_20180118_1.pdf
